BioCryst Pharmaceuticals 8-K 2006
SECURITIES AND EXCHANGE COMMISSION
Date of Report: February 8, 2006
BioCryst Pharmaceuticals, Inc.
2190 Parkway Lake Drive, Birmingham, Alabama 35244
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
Item 2.02. Results of Operations and Financial Condition:
On February 8, 2006, the Company issued a news release announcing its financial results for the quarter and year ended December 31, 2005, which also referenced a conference call to discuss these results and provide an update on the status of the Companys programs. A copy of the news release is furnished as exhibit 99.1 hereto and is incorporated by reference into Item 9.01 of Form 8-K.
Item 9.01. Financial Statements and Exhibits:
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.